Politics and Plan B
By Avni Patel
Administrative Law,
November 2005
On August 26, 2005, the Federal Food and Drug Administration (FDA) Commissioner, Dr. Lester M. Crawford, announced the postponement of a final decision regarding an application by Barr Laboratories on whether to allow nonprescription sales of its controversial emergency contraceptive pill, Plan B, for women over the age of 17.
Spot an error in your article? Contact Sara Anderson at sanderson@isba.org. For information on obtaining a copy of an article,visit the ISBA Newsletters page.
Select a Different Author
